Trivant Custom Portfolio Group, LLC Bristol Myers Squibb CO Transaction History
Trivant Custom Portfolio Group, LLC
- $174 Billion
- Q1 2025
A detailed history of Trivant Custom Portfolio Group, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Trivant Custom Portfolio Group, LLC holds 200 shares of BMY stock, worth $9,190. This represents 0.01% of its overall portfolio holdings.
Number of Shares
200
Previous 200
-0.0%
Holding current value
$9,190
Previous $11.3 Million
7.83%
% of portfolio
0.01%
Previous 0.01%
Shares
1 transactions
Others Institutions Holding BMY
# of Institutions
2,677Shares Held
1.58BCall Options Held
25.9MPut Options Held
24.1M-
Vanguard Group Inc Valley Forge, PA191MShares$8.79 Billion0.22% of portfolio
-
Black Rock Inc. New York, NY159MShares$7.29 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY108MShares$4.97 Billion0.52% of portfolio
-
State Street Corp Boston, MA94.8MShares$4.36 Billion0.24% of portfolio
-
Capital International Investors Los Angeles, CA66.5MShares$3.05 Billion0.83% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $97.7B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...